APA (7th ed.) Citation

H, H., NA, S., AR, A., S, L., P, C., C, S., . . . BJA, G. (2025). Seizure outcomes as an understudied metric in glioma clinical trials: A review of the ClinicalTrials.gov database. Neuro-oncology advances, 8(1), vdaf237. https://doi.org/10.1093/noajnl/vdaf237

Chicago Style (17th ed.) Citation

H, Haile, Shlobin NA, Adapa AR, Leskinen S, Canoll P, Schevon C, McKhann GM, and Gill BJA. "Seizure Outcomes as an Understudied Metric in Glioma Clinical Trials: A Review of the ClinicalTrials.gov Database." Neuro-oncology Advances 8, no. 1 (2025): vdaf237. https://doi.org/10.1093/noajnl/vdaf237.

MLA (9th ed.) Citation

H, Haile, et al. "Seizure Outcomes as an Understudied Metric in Glioma Clinical Trials: A Review of the ClinicalTrials.gov Database." Neuro-oncology Advances, vol. 8, no. 1, 2025, p. vdaf237, https://doi.org/10.1093/noajnl/vdaf237.